"Currently there are no tests that could be used for screening people for oropharyngeal cancer," said co-author Dr Carole Fakhry, an associate professor from Johns Hopkins Department of Otolaryngology, in a statement. "It is a rare cancer and for most healthy people the harms of screening for it would outweigh the benefits because of the problem of false positive test results and consequent anxiety.”
“Our research shows that identifying those who have oral HPV infection does not predict their future risk of cancer well, and so screening based on detecting cancer-causing oral HPV infection would be challenging," Fakhry added. "However, we are carrying out further research of oral HPV infection in young healthy men to explore this further."
Richard Shaw, a Cancer Research UK scientist from the University of Liverpool, shared earlier this year that there has been a debate about vaccinating not only young girls, but boys too. He also added that “along with vaccinating against HPV, helping people to quit smoking and cut down on alcohol are important.”